Idexx Laboratories IDXX CAG — Cost of revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's cag — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Idexx Laboratories's CAG — cost of revenue?
- Idexx Laboratories (IDXX) reported CAG — cost of revenue of $386.54M in Q1 2026.
- How has Idexx Laboratories's CAG — cost of revenue changed year-over-year?
- Idexx Laboratories's CAG — cost of revenue increased by 12.0% year-over-year, from $345.01M to $386.54M.
- What is the long-term trend for Idexx Laboratories's CAG — cost of revenue?
- Over 3 years (2022 to 2025), Idexx Laboratories's CAG — cost of revenue has grown at a 6.3% compound annual growth rate (CAGR), from $1.25B to $1.5B.
- What does CAG — cost of revenue mean?
- This metric captures the direct costs associated with producing and delivering the diagnostic products and services within the Companion Animal Group segment. It includes raw materials, manufacturing labor, and the costs of providing reference laboratory services. Monitoring this figure is essential for assessing the direct production efficiency and supply chain management of the segment.